These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8299019)

  • 1. Effects of sympathomimetic and sympatholytic drugs on exercise performance.
    McKeever KH
    Vet Clin North Am Equine Pract; 1993 Dec; 9(3):635-47. PubMed ID: 8299019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of a sympathomimetic drug on maximal aerobic capacity.
    De Meersman R; Schaefer D; Martelli M
    J Sports Med Phys Fitness; 1986 Sep; 26(3):251-7. PubMed ID: 3795919
    [No Abstract]   [Full Text] [Related]  

  • 3. [Behavior of blood catecholamines under the action of sympathomimetic and sympatholytic drugs].
    Di Biase G; Labriola E
    Arch Patol Clin Med; 1965 Dec; 42(2):114-25. PubMed ID: 5860702
    [No Abstract]   [Full Text] [Related]  

  • 4. Assessment of drug effects on performance.
    Kamerling SG
    Vet Clin North Am Equine Pract; 1993 Dec; 9(3):493-510. PubMed ID: 8299012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of sympathomimetic and sympatholytic agents on the salivary flow rate and concentration of Ca, P and protein in the parotid gland of the goat.
    Isac MD; Valverde A; Lupiani MJ; Martinez De Victoria E; Manas M
    Acta Physiol Hung; 1988; 72(3-4):291-6. PubMed ID: 3250209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sympathomimetics and exercise enhancement: all in the mind?
    DeMeersman R; Getty D; Schaefer DC
    Pharmacol Biochem Behav; 1987 Nov; 28(3):361-5. PubMed ID: 3685071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of sympathomimetic and sympatholytic agents in normotensive and hypertensive subjects.
    Kato M; Komata KE
    Tohoku J Exp Med; 1969 Mar; 97(3):213-31. PubMed ID: 5789718
    [No Abstract]   [Full Text] [Related]  

  • 8. The use of anti-asthmatic drugs. Do they affect sports performance?
    Fitch KD
    Sports Med; 1986; 3(2):136-50. PubMed ID: 2870555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges in detecting substances for equine anti-doping.
    Fragkaki AG; Kioukia-Fougia N; Kiousi P; Kioussi M; Tsivou M
    Drug Test Anal; 2017 Sep; 9(9):1291-1303. PubMed ID: 28087984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of sympathomimetic and sympatholytic agents on mesenteric hemodynamics in hemorrhagic hypotension.
    Nomoto S; Nakayama R; Tokura Y; Kimura Y
    Jpn J Surg; 1972 Sep; 2(3-4):141-55. PubMed ID: 4680069
    [No Abstract]   [Full Text] [Related]  

  • 11. [Behavior of experimental catatonia induced by bulbocapnine in rats under the action of various drugs. I. Action of sympathomimetic and sympatholytic substances].
    ALEMA G; SERGIO C
    Boll Soc Ital Biol Sper; 1957 Mar; 33(3):274-6. PubMed ID: 13446289
    [No Abstract]   [Full Text] [Related]  

  • 12. Interactions of sympathomimetic drugs and their antagonists on the isolated atrium.
    BENFEY BG; GREEFF K
    Br J Pharmacol Chemother; 1961 Oct; 17(2):232-5. PubMed ID: 13867194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonsteroidal anti-inflammatory drugs.
    Kallings P
    Vet Clin North Am Equine Pract; 1993 Dec; 9(3):523-41. PubMed ID: 8299014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacology of a series of new sympatholytic agents.
    NICKERSON M; GOODMAN LS
    Rocky Mt Med J; 1947 Apr; 44(4):290. PubMed ID: 20290044
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical pharmacology of the gastrointestinal tract.
    Clark ES; Becht JL
    Vet Clin North Am Equine Pract; 1987 Apr; 3(1):101-22. PubMed ID: 3555722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Some aspects of doping and medication control in equine sports.
    Houghton E; Maynard S
    Handb Exp Pharmacol; 2010; (195):369-409. PubMed ID: 20020374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacology of a series of new sympatholytic agents (tertiary amines).
    NICKERSON M; GOODMAN LS
    Proc Am Fed Clin Res; 1945; 2():109. PubMed ID: 20275649
    [No Abstract]   [Full Text] [Related]  

  • 18. Veterinary medicines and competition animals: the question of medication versus doping control.
    Toutain PL
    Handb Exp Pharmacol; 2010; (199):315-39. PubMed ID: 20204593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of sympathomimetic amines on the blocking action of guanethidine, bretylium and xylocholine.
    DAY MD
    Br J Pharmacol Chemother; 1962 Apr; 18(2):421-39. PubMed ID: 13884064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ergogenic aids to performance in the race horse: nutrients or drugs.
    Snow DH
    J Nutr; 1994 Dec; 124(12 Suppl):2730S-2735S. PubMed ID: 7996281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.